Compounds, vectors and methods for expressing human, cytosolic phospholipase A.sub.2
US5328842A · kind A · utility
15Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 1993 |
| Grant date | Jul 12, 1994 |
| Priority date | — |
| Expiry date | Apr 12, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention includes recombinant DNA compounds, vectors and methods useful for expressing an exceptionally rare, human, cytosolic phospholipase A.sub.2 (cPLA.sub.2) enzyme. The invention also includes a method for screening compounds to identify inhibitors of cPLA.sub.2 which is believed to partake in several disease processes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.